As with randomization, if allocation to the study drug is not carried out in accordance with the protocol, the entire study ...

Journey Medical dermatology revenue plus Emrosi near-term sales and a rare pediatric disease PRV from Zycubo approval. See ...

Does ‘Bugonia’ turn out to be a tense thriller about delusion, or a sci-fi movie about aliens?

Sepsis, a life-threatening response to infection, is a major cause of death in U.S. hospitals, and early treatment is critical. The flag prompted the charge nurse to instruct Hart to room the patient ...

MENLO PARK, Calif., Feb. 19, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today reported business and financial ...

Subvisible particle testing addresses regulatory limits for particulate matter in parenteral drugs, ophthalmic solutions, and lipid emulsions.

Spero Therapeutics’ oral antibiotic tebipenem shows Phase 3 success and supports GSK’s NDA resubmission. Click here to read my latest analysis of SPRO stock.

IRADIMED CORPORATION (the 'Company” or 'Iradimed”) (NASDAQ: IRMD) announced today its financial results for the quarter and ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the fourth quarter and ...

A nose-to-brain drug delivery approach leverages neural pathways to achieve high brain exposure with low systemic levels, offering a non-invasive alternative to transporter-based BBB strategies for ...

Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results for the quarter and year ended December 31, ...

Sold More Than 185,000 Galleri® Tests in 2025, Growing U.S. Galleri Revenue 26% Year-Over-Year to $136.8 Million Completed Galleri PMA Submission to FDA Shared Topline ...